Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5224_Библиотеки_им_академика_М_И_Перельмана.pdf
X
- •Contents
- •Outcome Evaluation
- •Introduction
- •Clinical Presentation of Muscular Weakness in the Critical Patients
- •Critical Illness Polyneuropathy (CIP) and Critical Illness Myopathy (CIM)
- •Ventilator-Induced Diaphragmatic Dysfunction (VIDD)
- •Dysphagia, Swallowing, and Effective Cough
- •The Pathophysiology of Acute Skeletal Muscle Wasting
- •Risk Factors
- •Short-Term and Long-Term Outcome
- •Conclusions
- •References
- •Introduction
- •The Neuroendocrine Response
- •Pathophysiology of Stress Response
- •The Hypothalamus-Pituitary-Adrenal (HPA) Axis
- •GH Axis
- •Pituitary-Thyroid Axis
- •Pituitary-Adrenal Axis
- •Mitochondrial Dysfunction
- •Metabolic Aspects of Stress Response
- •Conclusion
- •References
- •Introduction
- •Disorders of Fluid Balance
- •Dysionemias
- •Dysnatremias
- •Dyskalemias
- •Other Electrolyte Derangements (Calcium, Magnesium, Phosphorus)
- •Alterations of Acid Base Balance
- •Acid-Base Disturbances
- •Metabolic Acidosis
- •Respiratory Acidosis
- •Metabolic Alkalosis
- •Respiratory Alkalosis
- •Conclusion
- •References
- •Introduction
- •Epidemiology and Risk Factors
- •Diagnosis
- •Differential Diagnosis
- •Treatment
- •Prognosis
- •Future Perspectives
- •References
- •Introduction
- •Gut Microbiome
- •Gut-Organ Axis
- •Gut-Lung Axis
- •ICU Dysbiosis
- •Gut Changes
- •Microbial Therapy in ICU
- •Antimicrobial Stewardship
- •Nutrition as a Key Factor for Gut Microbiome Homeostasis
- •Probiotics, Prebiotics, and Synbiotics
- •Fecal Microbiota Transplantation
- •Conclusion
- •References
- •Introduction
- •Validation Process
- •Screening Tools Overview
- •Discussion
- •Conclusion
- •References
- •Introduction
- •Fight-and-Flight Reaction
- •Calorimetry and Total Energy Expenditure
- •Role of Mitochondria in the Various Stages of Intensive Care Recovery
- •REE in Different Clinical Scenarios
- •Conclusions
- •References
- •Introduction
- •Nutrition in ICU: Evidence from RCTs
- •Inclusion of Too Many Patients Considered at Low Nutritional Risk
- •Unfavorable Energy to Protein Doses
- •Absence of Indirect Calorimetry-Guided Energy Dosing
- •Anabolic Resistance
- •Suppression of Fasting-Induced Recovery Pathways
- •Future Perspectives
- •Development and Validation of Tools to Guide Individualized Nutritional Support
- •Implications for Clinical Practice
- •Conclusion
- •References
- •Introduction
- •Protein Metabolism in Critical Illness
- •Protein Requirements and Current Evidence
- •Timing of Introduction
- •Early mobilization, Exercise, and Adjuvant Therapies
- •Conclusion
- •References
- •Introduction
- •Computed Tomography Scan
- •Bioelectrical Impedance Analysis
- •Musculoskeletal Ultrasound
- •Respiratory Muscle Ultrasound
- •Limb Muscles
- •Conclusions
- •References
- •Functional Principles
- •Hydration Status Evaluations in Critically Ill Patients
- •Body Composition and Nutrition in ICU
- •Limits of BIVA in Critically Ill Patients
- •Conclusions
- •References
- •Introduction
- •Introduction
- •Historical Perspective
- •Enteral Versus Parenteral Nutrition Nowadays
- •Conclusions
- •References
- •Enteral Nutrition
- •Components of Enteral Mixtures
- •Choice of the Enteral Mixture
- •Special Composition Formulas
- •Conclusions
- •References
- •Introduction
- •Complications Related to Enteral Feeding Tubes
- •Aspiration
- •Gastrointestinal Intolerance
- •Diarrhea
- •New Horizons
- •New Technologies to Prevent Enteral Nutrition Complications
- •Advanced Tube Feedings
- •smART Platform
- •Conclusions
- •References
- •Introduction
- •Composition of PN Admixtures
- •Energetic Substrates
- •Carbohydrates
- •Lipid Emulsions
- •Proteins
- •Micronutrients: Electrolytes, Vitamins, and Trace Elements
- •Types of Parenteral Nutrition
- •Compatibility and Stability of the Parenteral Nutrition
- •References
- •Introduction
- •Metabolic Complications
- •Hyperglycemia
- •Hypertriglyceridemia
- •Liver Disease: Steatosis, Cholestatic Disease, and Gallbladder Stones
- •Refeeding Syndrome
- •Mechanical Complications
- •Infectious Complications
- •Conclusions
- •References
- •Introduction
- •Macronutrients
- •Glutamine
- •Arginine
- •Leucine
- •ω-3 Fatty Acids
- •Micronutrients
- •Antioxidant Vitamins
- •Antioxidant Trace Elements
- •Probiotics, Prebiotics or Symbiotics
- •Use of Probiotics in Clinical Practice?
- •References
- •Introduction
- •Pathophysiological Mechanisms, Risk Factors, and Clinical Implications
- •Pathophysiological Mechanisms of ICUAW
- •Risk Factors Associated with Physical and Functional Recovery in Critically Ill Patients
- •Clinical Impact of Poor Physical and Functional Recovery in Critical Illnesses
- •How to Assess Physical and Functional Recovery in Critical Illnesses
- •Management and Therapies
- •Nutritional Therapy
- •Other Supportive Therapies
- •Patient- and Family-centered ICU Environment
- •Conclusions
- •References
- •Bioethics in Clinical Practices
- •Ethical Consideration on Nutrition
- •Conclusion
- •References
- •Introduction
- •Nutrition in ARDS
- •Caloric Goals
- •Diet Composition
- •Immunonutrition
- •Oral Versus Enteral Versus Parenteral Nutrition
- •Nutrition in COVID-19 Respiratory Failure
- •Nutrition in ECMO Support
- •Enteral Nutrition
- •Parenteral Nutrition
- •Nutritional Goals
- •Conclusions
- •References
- •Introduction
- •Timing and Route of Nutritional Support
- •Initial Assessment of the Burn Patient
- •Estimation of Energy Expenditure
- •Macronutrients and Micronutrients
- •Proteins
- •Carbohydrates
- •Immunonutrients
- •Arginine
- •Nucleotides
- •ω3 Fatty Acids
- •Glutamine
- •Monitoring of Nutritional Support
- •Nutritional Support for Trauma Patients
- •Route of Feeding: Digestive Tract (Enteral Nutrition) Versus Intravenous (Parenteral Nutrition)
- •Standard or Immune-Enhancing Enteral Nutrition
- •Estimation or Measurement of Energy Requirements
- •Macronutrients
- •Conclusions
- •References
- •Introduction
- •General Considerations
- •Assessment of Nutritional Needs
- •Metabolic Changes Induced by Sepsis, AKI, and CRRT
- •Protein Metabolism
- •Lipid Metabolism
- •Vitamins and Trace Elements
- •Phosphates
- •Approaches to Nutrition
- •Enteral
- •Parenteral
- •Timing
- •Recommendations
- •Conclusion
- •References
- •Introduction
- •Acute Liver Failure
- •Nutrition in ALF
- •Acute Pancreatitis
- •IAP Management
- •Conclusions
- •References
- •Introduction
- •Nutritional Considerations in Major Surgery
- •Nutritional Requirements During and After Major Surgery
- •Challenges in Meeting Nutritional Needs Post-Surgery
- •Strategies for Enhancing Nutritional Intake and Absorption
- •Intestinal Failure: Nutritional Challenges and Management
- •Impact of Intestinal Failure on Nutritional Status
- •Nutritional Management Strategies for Patients with Intestinal Failure
- •Role of Parenteral Nutrition and Enteral Nutrition in Intestinal Failure Cases
- •Open Abdomen: Nutritional Support and Wound Healing
- •Nutritional Requirements for Patients with Open Abdomen Wounds
- •Challenges in Providing Nutritional Support to Patients with Open Abdomen
- •Clinical Protocols and Guidelines for Nutritional Support
- •Conclusions
- •References
- •Introduction
- •Nutrition Therapy
- •Determination of Energy Expenditure
- •Route and Timing of Enteral Nutrition
- •Intolerance to Enteral Nutrition
- •Brain Energy Metabolism and Energy Dysfunction Following Acute Brain Injury
- •In Vivo Brain Energy and Glucose Monitoring
- •Alternative Energy Substrates
- •Lactate
- •Ketone Bodies
- •Immunonutrition and Micronutrients
- •Conclusions and Future Directions
- •References
- •Introduction
- •AKI and Cardiac Surgery
- •AKI and Vascular Surgery
- •AKI and Sepsis
- •AKI and Surgery
- •Trauma
- •Burn
- •AKI and COVID-19
- •Conclusion
- •References
- •Introduction
- •AKI Etiology
- •Subclinical AKI and AKI Biomarkers
- •Subphenotyping AKI
- •Conclusions
- •References
- •Introduction
- •What Are Biomarkers?
- •Novel Biomarkers: How Can They be Implemented?
- •Biomarkers for the Prediction of AKI and Detection of Subclinical Stages
- •Postoperative Biomarker-Guided Prevention of AKI in Patients at High Risk
- •Biomarkers for Other Indications
- •Conclusion
- •References
- •Introduction
- •The Machine Learning Arena
- •The Challenges of Timely Prediction of Acute Kidney Injury
- •Early Machine Learning Models for AKI Prediction
- •New Techniques for AKI Prediction Using Deep Learning ML Models
- •Clinical Decision Support Systems
- •The Translational Research Gap and the Value of Data Sharing: A Plea for Data Sharing
- •Limitations of Machine Learning Models
- •Conclusions
- •References
- •Introduction
- •Doppler Assesses Vascular Congestion
- •Arterial Renal Doppler Ultrasound in AKI
- •Integration of Renal Resistive Index and Intrarenal Venous Flow
- •Contrast-Enhanced Ultrasound for Assessing Renal Perfusion
- •Conclusions
- •References
- •Introduction
- •Renal Perfusion and Goals of Fluids in AKI
- •Clinical Evaluation of a Patient with AKI in ICU
- •Studies Which Investigated the Association of Fluid Therapy and AKI
- •Volume of Fluid
- •Type of Fluid
- •Crystalloids
- •Colloids
- •Starches
- •Gelatins
- •Conclusion
- •References
- •Introduction
- •Pathophysiology of Renal Perfusion
- •Acute Kidney Injury
- •Norepinephrine
- •Epinephrine
- •Dopamine
- •Vasopressin
- •Terlipressin
- •Angiotensin II
- •Conclusions
- •References
- •Introduction
- •Pharmacology of Diuretics
- •Loop Diuretics
- •Other Classes of Diuretics
- •Indications for Diuretics in AKI
- •Control of Fluid Overload
- •AKI Prognostication
- •Situations in Which Diuretics Are Not Indicated
- •AKI Recovery
- •How to Use Diuretics in the ICU
- •Class and Dose Selection
- •Modality of Loop Diuretic Administration
- •Conclusions
- •References
- •Introduction
- •What Is Acute Kidney Disease?
- •Clinical Course of AKD Within the ICU
- •Management of AKD in Critical Care and Beyond
- •Conclusions and Future Directions
- •References
- •Introduction
- •Renal Functional Reserve
- •Renal Functional Reserve and Renal Recovery After Acute Kidney Injury
- •Conclusion
- •References
- •Background
- •Membrane and Filter Characteristics
- •Geometric Characteristics
- •Performance Characteristics
- •Mechanisms of Fluid and Solute Transport
- •Treatment Modalities
- •Treatment Dose
- •Nomenclature of Renal Replacement Therapies
- •Continuous Therapies
- •Intermittent Therapies
- •Hybrid Therapies
- •Conclusion
- •References
- •Introduction
- •Dialysis Catheters: Technical Aspects
- •Selection of the Site for Dialysis
- •Catheter Insertion Technique
- •Dialysis Catheter Complications
- •Dialysis Catheter Maintenance
- •Conclusions
- •References
- •Introduction
- •Non-pharmacological Strategies to Reduce Membrane Fouling
- •Pharmacological Strategies to Reduce Membrane Clotting
- •Unfractionated Heparin (UFH) Systemic Anticoagulation
- •Systemic Anticoagulation with Low Molecular Weight Heparin (LMWH)
- •Regional Citrate Anticoagulation (RCA)
- •Systemic Anticoagulation with Direct Thrombin Antagonists
- •Nafamostat
- •Conclusions
- •References
- •Introduction
- •CRRT Dose/Outcome Studies: Consideration of Solute Kinetics
- •CRRT Dose as a Quality Criterion
- •CRRT Dose in the Context of Therapy Quality
- •Conclusions
- •References
- •Introduction
- •Patient Selection and Indications for Starting RRT
- •Strategies to Identify Need for RRT
- •Rationale for an Early Strategy to Starting RRT
- •Rationale for a Conservative Strategy to Starting RRT
- •RRT Replacement Therapy and Clinical Outcomes
- •Current Clinical Practice Guideline Recommendations
- •Clinical Trial Evidence on Timing of Starting RRT
- •Implications for Practice
- •Existing Knowledge Gaps and Future Research
- •Conclusions
- •References
- •Introduction
- •Early ICU Phase before KRT
- •Nutrition Care
- •Monitoring
- •ICU Phase with KRT
- •Gains and Losses During CRRT
- •Electrolyte Loss in CRRT
- •Macronutrient Loss in CRRT
- •Macronutrient Gain in CRRT
- •Micronutrients and Vitamin Loss in CRRT
- •Management of Losses During CRRT
- •Monitoring During CRRT
- •Indirect Calorimetry During CRRT
- •ICU Phase After CRRT
- •EN and PN Product Selection
- •Conclusions
- •References
- •Introduction
- •Nomenclature
- •Continuous Therapies
- •Intermittent Renal Replacement Therapies (IRRTs)
- •Hybrid Therapies
- •Technical Aspects of RRT Techniques
- •Hemodynamic Stability
- •Solute Clearance
- •Fluid Balance
- •Vascular Access
- •Anticoagulation
- •Drug Dosing
- •Patient Mobilization
- •The Process of RRT Prescription and Administration
- •Indications of RRT
- •Timing
- •Prescription Parameters
- •Dosing
- •Membrane Choice
- •Dialysate and Reinfusion Solutions
- •Limitations of RRT in Critical Care
- •Patient Safety During RRT in Critical Care
- •Introduction
- •Steps in RRT Management and Protocol Application

116 M. Umbrello et al.
6. Singer P, Blaser AR, Berger MM, Alhazzani W, Calder PC, Casaer MP, et al. ESPEN guideline
on clinical nutrition in the intensive care unit. Clin Nutr. 2019;38(1):48–79. https://doi.org/10.
1016/j.clnu.2018.08.037.
7. Wischmeyer PE. Tailoring
3):316. https://doi.org/10.1186/s13054-017-1906-8.
8. Ackermans L, Rabou J, Basrai M, Schweinlin A,
diagnosis and monitoring of sarcopenia: when to use which tool? Clin Nutr ESPEN. 2022;48:
36–44. https://doi.org/10.1016/j.clnesp.2022.01.027.
9. Aubrey J, Esfandiari N, Baracos VE, Buteau FA, Frenette J, Putman CT, et al. Measurement of
skeletal muscle radiation attenuation and basis of its biological variation. Acta Physiol (Oxf).
2014;210(3):489–97. https://doi.org/10.1111/apha.12224.
10. De Marco D, Mamane S, Choo W, Mullie L, Xue X, Afilalo M, et al. Muscle area and density
assessed by abdominal computed tomography in healthy adults: effect of normal aging and
derivation of reference values. J Nutr Health Aging. 2022;26(2):243–6. https://doi.org/10.1007/
s12603-022-1746-3.
11. Looijaard WG, Dekker IM, Stapel SN, Girbes AR, Twisk JW, Oudemans-van Straaten HM,
et al. Skeletal muscle quality as assessed by CT-derived skeletal muscle density is associated
with 6-month mortality in mechanically ventilated critically ill patients. Crit Care. 2016;20(1):
386. https://doi.org/10.1186/s13054-016-1563-3.
12. Zhang XM, Chen D, Xie XH, Zhang JE, Zeng Y, Cheng AS. Sarcopenia as a predictor of
mortality among the critically ill in an intensive care unit: a systematic review and metaanalysis. BMC Geriatr. 2021;21(1):339. https://doi.org/10.1186/s12877-021-02276-w.
13. Joppa P, Tkacova R, Franssen FM, Hanson C, Rennard SI, Silverman EK, et al. Sarcopenic
obesity, functional outcomes, and systemic inflammation in patients with chronic obstructive
pulmonary disease. J Am Med Dir Assoc. 2016;17(8):712–8. https://doi.org/10.1016/j.jamda.
2016.03.020.
14. Prado CM, Lieffers JR, McCargar LJ, Reiman T, Sawyer MB, Martin L, et al. Prevalence and
clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and
gastrointestinal tracts: a population-based study. Lancet Oncol. 2008;9(7):629–35. https://doi.
org/10.1016/S1470-2045(08)70153-0.
15. Mourtzakis M, Prado CM, Lieffers JR, Reiman T, McCargar LJ, Baracos VE. A practical and
precise approach to quantification of body composition in cancer patients using computed
tomography images acquired during routine care. Appl Physiol Nutr Metab. 2008;33(5):
997–1006. https://doi.org/10.1139/H08-075.
16. Kyle UG, Bosaeus I, De Lorenzo AD, Deurenberg P, Elia M, Gomez JM, et al. Bioelectrical
impedance analysis – part I: review of principles and methods. Clin Nutr. 2004;23(5):1226–43.
https://doi.org/10.1016/j.clnu.2004.06.004.
17. Moonen H, Van Zanten ARH. Bioelectric impedance analysis for body composition measurement and other potential clinical applications in critical illness. Curr Opin Crit Care. 2021;27(4):
344–53. https://doi.org/10.1097/MCC.0000000000000840.
18. Formenti P, Umbrello M, Coppola S, Froio S, Chiumello D. Clinical review: peripheral
muscular ultrasound in the ICU. Ann Intensive Care. 2019;9(1):57. https://doi.org/10.1186/
s13613-019-0531-x.
19. Lima J, Eckert I, Gonzalez MC, Silva FM. Prognostic value of phase angle and bioelectrical
impedance vector in critically ill patients: a systematic review and meta-analysis of observational studies. Clin Nutr. 2022;41(12):2801–16. https://doi.org/10.1016/j.clnu.2022.10.010.
20. Looijaard W,
fying critically ill patients with low muscle mass: agreement between bioelectrical impedance
analysis and computed tomography. Clin Nutr. 2020;39(6):1809–17. https://doi.org/10.1016/j.
clnu.2019.07.020.
21.
De Rui M, Veronese N, Bolzetta F, Berton L, Carraro S, Bano G, et al. Validation of
bioelectrical impedance analysis for estimating limb lean mass in free-living Caucasian elderly
people. Clin Nutr. 2017;36(2):577–84. https://doi.org/10.1016/j.clnu.2016.04.011.
Stapel
nutrition therapy to illness and recovery. Crit Care. 2017;21(Suppl
Bischoff SC, Cussenot O, et al. Screening,
SN, Dekker IM, Rusticus H, Remmelzwaal S, Girbes ARJ, et al. Identi-

10 Monitoring of Muscle Mass in Critically Ill Patients 117
22. Tuinman PR, Jonkman AH, Dres M, Shi ZH, Goligher EC, Goffi A, et al. Respiratory muscle
ultrasonography: methodology, basic and advanced principles
and ED patients-a narrative review. Intensive Care Med. 2020;46(4):594–605. https://doi.org/
10.1007/s00134-019-05892-8.
23. Haaksma ME, Smit JM, Boussuges A, Demoule A, Dres M, Ferrari G, et al. EXpert consensus
On Diaphragm UltraSonography in the critically ill (EXODUS): a Delphi consensus statement
on the measurement of diaphragm ultrasound-derived parameters in a critical care setting. Crit
Care. 2022;26(1):99. https://doi.org/10.1186/s13054-022-03975-5.
24. Umbrello M, Formenti P, Lusardi AC, Guanziroli M, Caccioppola A, Coppola S, et al.
Oesophageal pressure and respiratory muscle ultrasonographic measurements indicate inspiratory effort during pressure support ventilation. Br J Anaesth. 2020;125(1):e148–57. https://doi.
org/10.1016/j.bja.2020.02.026.
25. Umbrello M, Formenti P. Ultrasonographic assessment of diaphragm function in critically ill
subjects. Respir Care. 2016;61(4):542–55. https://doi.org/10.4187/respcare.04412.
26. Cardenas LZ, Santana PV, Caruso P, Ribeiro de Carvalho CR, Pereira de Albuquerque
AL. Diaphragmatic ultrasound correlates with inspiratory muscle strength and pulmonary
function in healthy subjects. Ultrasound Med Biol. 2018;44(4):786–93. https://doi.org/10.
1016/j.ultrasmedbio.2017.11.020.
27. Boussuges A, Rives S, Finance J, Chaumet G, Vallee N, Risso JJ, et al. Ultrasound assessment
of diaphragm thickness and thickening: reference values and limits of normality when in a
seated position. Front Med (Lausanne). 2021;8:742703. https://doi.org/10.3389/fmed.2021.
742703.
28. Vivier E, Mekontso Dessap A, Dimassi S, Vargas F, Lyazidi A, Thille AW, et al. Diaphragm
ultrasonography to estimate the work of breathing during non-invasive ventilation. Intensive
Care Med. 2012;38(5):796–803. https://doi.org/10.1007/s00134-012-2547-7.
29. Goligher EC, Laghi F, Detsky ME, Farias P, Murray A, Brace D, et al. Measuring diaphragm
thickness with ultrasound in mechanically ventilated patients: feasibility, reproducibility and
validity. Intensive Care Med. 2015;41(4):642–9. https://doi.org/10.1007/s00134-015-3687-3.
30. Turton P, Hay R, Taylor J, McPhee J, Welters I. Human limb skeletal muscle wasting and
architectural remodeling during five to ten days intubation and ventilation in critical care - an
observational study using ultrasound. BMC Anesthesiol. 2016;16(1):119. https://doi.org/10.
1186/s12871-016-0269-z.
31. Seymour JM, Ward K, Sidhu PS, Puthucheary Z, Steier J, Jolley CJ, et al. Ultrasound
measurement of rectus femoris cross-sectional area and the relationship with quadriceps
strength in COPD. Thorax. 2009;64(5):418–23. https://doi.org/10.1136/thx.2008.103986.
32. Silva CRS, Costa ADS, Rocha T, de Lima DAM, do Nascimento T, de Moraes SRA.
Quadriceps muscle architecture ultrasonography of individuals with type 2 diabetes: reliability
and applicability. PLoS One. 2018;13(10):e0205724. https://doi.org/10.1371/journal.pone.
0205724.
33. Pardo E, El Behi H, Boizeau P, Verdonk F, Alberti C, Lescot T. Reliability of ultrasound
measurements of quadriceps muscle thickness in critically ill patients. BMC Anesthesiol.
2018;18(1):205. https://doi.org/10.1186/s12871-018-0647-9.
34. Mayer KP, Thompson Bastin ML, Montgomery-Yates AA, Pastva AM, Dupont-Versteegden
EE, Parry SM, et al. Acute skeletal muscle wasting and dysfunction predict physical disability at
hospital discharge in patients with critical illness. Crit Care. 2020;24(1):637. https://doi.org/10.
1186/s13054-020-03355-x.
35. Pillen S, van Dijk JP, Weijers G, Raijmann W, de Korte CL, Zwarts MJ. Quantitative gray-scale
analysis in skeletal muscle ultrasound: a comparison study of two ultrasound devices. Muscle
Nerve. 2009;39(6):781–6. https://doi.org/10.1002/mus.21285.
Strasser EM,
36.
measurements of muscle thickness, pennation angle, echogenicity and skeletal muscle strength
in the elderly. Age (Dordr). 2013;35(6):2377–88. https://doi.org/10.1007/s11357-013-9517-z.
Draskovits T, Praschak M, Quittan M, Graf A. Association between ultrasound
and clinical applications in ICU

118 M. Umbrello et al.
37. Paolo F, Valentina G, Silvia C, Tommaso P, Elena C, Martin D, et al. The possible predictive
value of muscle ultrasound in the diagnosis of ICUAW
in long-term critically ill patients. J Crit
Care. 2022;71:154104. https://doi.org/10.1016/j.jcrc.2022.154104.
38. da Silva Passos LB, Macedo TAA, De-Souza DA. Nutritional state assessed by ultrasonography, but not by bioelectric impedance, predicts 28-day mortality in critically ill patients.
Prospective cohort study. Clin Nutr. 2021;40(12):5742–50. https://doi.org/10.1016/j.clnu.
2021.10.015.
39. Gruther W, Benesch T, Zorn C, Paternostro-Sluga T, Quittan M, Fialka-Moser V, et al. Muscle
wasting in intensive care patients: ultrasound observation of the M. quadriceps femoris muscle
layer. J Rehabil Med. 2008;40(3):185–9. https://doi.org/10.2340/16501977-0139.
40. Arai Y, Nakanishi N, Ono Y, Inoue S, Kotani J, Harada M, et al. Ultrasound assessment of
muscle mass has potential to identify patients with low muscularity at intensive care unit
admission: a retrospective study. Clin Nutr ESPEN. 2021;45:177–83. https://doi.org/10.1016/
j.clnesp.2021.08.032.
41. Fischer A, Hahn R, Anwar M, Hertwig A, Pesta M, Timmermann I, et al. How reliably can
ultrasound help determine muscle and adipose tissue thickness in clinical settings? An assessment of intra- and inter-examiner reliability in the USVALID study. Eur J Clin Nutr. 2022;76
(3):401–9. https://doi.org/10.1038/s41430-021-00955-w.
42. Umbrello M, Guglielmetti L, Formenti P, Antonucci E, Cereghini S, Filardo C, et al. Qualitative
and quantitative muscle ultrasound changes in patients with COVID-19-related ARDS. Nutrition. 2021;91-92:111449. https://doi.org/10.1016/j.nut.2021.111449.
43. Palakshappa JA,
Reilly JP, Schweickert WD, Anderson BJ, Khoury V, Shashaty MG, et al.
Quantitative peripheral muscle ultrasound in sepsis: muscle area superior to thickness. J Crit
Care. 2018;47:324–30.
https://doi.org/10.1016/j.jcrc.2018.04.003.

Chapter 11
Bioelectrical Impedance Vector Analysis
in Critically Ill Patients
Cristian Deana, Sara Samoni, and Rinaldo Bellomo
Introduction
Critically ill patients with organ failure develop important disruptions of normal
body composition. Acute illness is often associated with increased capillary permeability and inte rstitial fluid accumulation [1].
Robust evidence suggests that a strongly positive fluid balance in intensive care
(ICU) is associated with increased mortality [2, 3].
unit
Finally, critically ill patients are also characterized by wide variations in their
carbohy
catabolism, which leads to muscular dysfunction, and ICU-acquired weakness
(ICU-AW) [4].
drate, lipid, and protein metabolism and critical illness increases protein
Supplementary Information The online version contains supplementary material available at
https://doi.org/10.1007/978-3-031-66541-7_11.
C. Deana (
Department of Anesthesia and Intensive Care, Health Integrated Agency of Friuli Centrale,
Udine, Italy
S. Samoni
Department of Nephrology, Dialysis and Renal Transplantation, Fondazione IRCCS Ca’
Granda Ospedale Maggiore Policlinico, Milan, Italy
R. Bellomo
Australian and New Zealand Intensive Care Research Centre (ANZIC-RC), School of Public
Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia
Department of Critical Care, University of Melbourne, Melbourne, VIC, Australia
Department of Intensive Care, Austin Hospital, Melbourne, VIC, Australia
Department of Intensive Care, Royal Melbourne Hospital, Melbourne, VIC, Australia
e-mail: Rinaldo.BELLOMO@austin.org.au
© The
A. Cotoia et al. (eds.), Nutrition, Metabolism and Kidney Support,
https://doi.org/10.1007/978-3-031-66541-7_11
✉)
Author(s), under exclusive license to Springer Nature Switzerland AG 2024
119

120 C. Deana et al.
As a result, real-time knowledge of body composition may be of value in
optimizing fluid status, nutritional therapy, and drug dosing.
Some techniques are available for this purpose. However, many of them are based
on radiation techniques (Dual-Energy X-Ray absorptiometry (DEXA)), computed
tomography (CT), or need isotopes to determine water content. Others require the
transfer of patients to the radiology suite with increased workload and exposure of
critically ill patients to mobilization-related risks [5].
Given such challenges, bioelectric impedance vector analysis (BIVA) appears
attractive because it is a non-invasive, easy to use, inexpensive bedside tool that has
interesting potential applications in ICU.
Functional Principles
BIVA evaluates some characteristics of tissues, mainly hydration status, in response
to an application of alternate current [
Electrolyte-rich tissues are highly conductive of electrical current, while anhydrous tissues (like fat) resist the flow of current.
In simple words, the opposition to flow of a current is called resistance (R), while
the opposition to a curren t change due to a capacitor is defined as reactance (X
sum of resistance and reactance gives the impedance dimension (I) according to the
following formula: I
2
2
= X
+ R2 [8, 9]. Considering the participant’s height in the
c
regression equations, BIA can estimate lean body mass from impedance values and
body water content [
10].
There are many tools available on the market for this clinical purpose.
Single frequency BIVA (SF-BIVA) machines use a 50 kHz current to estimate
impedance. Low frequency machines usually measure only extracellular water
(ECW); thus, total body water (TBW) is derived from proportional equations [11].
High frequency currents, instead, provide data on intracellular water (ICW) and
ECW directly from measurement [
For this reasons, multifrequency devices have some advantages. Estimation of
TBW, ICW, and ECW is more reliable [13].
In addition, some machines adopt a multifrequency (MF-BIVA or bioimpedance
spectroscopy) current that provides more data.
In the case of huge amount of cell membranes to be crossed by high frequency
current, BIVA will measure a high X
and R are also included in the determination of Phase angle (PA). This
X
c
parameter represents the arctangent (X
The PA derives from a phase shift caused by resistance to flow determined by
capacitors (i.e., healthy cell membranes) that delay the current’s flow [
racti
In p
ce, a high PA correlates with large quantities of intact cell membranes
and body cell mass [15].
PA is
affected by age (lower at higher age) and sex (higher in men due to a greater
muscle mass to water content ratio) [16].
6, 7].
12].
value.
c
/R) * (180/π ).
c
14].
). The
c

11 Bioelectrical Impedance Vector Analysis in
Critically Ill Patients 121
BIVA depicts impedance as the vector of Xc and R in an x–y Cartesian axis. An R-
graph simultaneously describes hydration status and body composition. It has
X
c
been validated in healthy individuals and it is widely used in maintenance hemodialysis and peritoneal dialysis patients [
17].
Finally, bioimpedance spectroscopy (BIS) measures impedance by varying fre-
quencies, from very low to about 1000 KHz. According to Cole’s model, BIS fits the
impedance to a mathematical model that best describes X
and R. Theoretically, BIS
c
does not assume that ECW and ICW are uniformly distributed, so this technique
seems to give more accurate and individualized measure of ECW, ICW, and TBW
when compared to SF-BIVA or MF-BIVA [18].
Nonetheless, equations used to estimate volumes rely on constants that could
introduce some bias during calculation.
Old BIVA machines considered the body as a single cylinder. However, this does
not re flect possible asymmetry between right and left side of the body, or difference
between limbs and trunk, for example.
Technology has overcome this limit with segmental BIVA devices that consider
the body as five separate cylinders, using electrodes on all limbs as shown in
Fig. 11.1.
Fig. 11.1 First BIVA machines considered the body as one cylinder as shown in the left part of the
figure. Whole-body impedance was then used to calculate body water volumes. As devices
improved, with segmental BIVA the body was split into five cylinders with a separate analysis of
impedance in each cylinder. The latter improved accuracy in estimating body composition (right
part of the figure)

122 C. Deana et al.
Hydration Status Evaluations in Critically Ill Patients
Accumulation of fluids in ICU patients is frequently observed [19]. Overzealous
fluid administration in septic patients or those with shock is the typical scenario
where concomitant capillary leak and large amounts of fluids increase the ECW [20].
In contrast, poor hydration status might impair organ perfusion (if concomitant
hypovolemia is present) leading to injury and derangement of physiological
function.
Excessive negative or positive cumulative fluid balance significantly affects
critically ill patients’ outcomes [21, 22].
In fact, excessive fluid accumulation has been related to increased duration of
mechanical ventilation, ICU, and hospital length of stay (LOS), acute kidney injury,
and mortality [23].
However, it is difficult to estimate the patient’s volume status in ICU.
The gold standard for estimating the body water content is the use of tracers such
as deuterium oxide. However, this is not applicable in critically ill patients in daily
clinical practice [24].
In addition, classical hemodynamic parameters such as central venous pressure
(CVP) or arterial pressure (AP) are unreliable markers of TBW or ICW or ECW
[25]. Similarly, estimated cumulative fluid balance is subject to errors (for example,
insensible losses are very difficult to determine in case of fever).
In this regard, BIVA seems to be a reliable and easy to use method for assessing
fluid overhydration in ICU. To allow easier interpretation of BIVA data, an algorithm has been developed to finally convert bioelectrical parameters into a synthetic
measure of lean body mass hydration percentage [26]. According to this numerical
scale, patients can be classified as dehydrated, normohydrated, and hyperhydrated.
Jones and Colleagues described that hydration status changes given by BIVA
were consistent with directional changes in fluid balance. In other words, patients
classified as “dehydrated” at ICU admission had positive cumulative fluid balance at
day 5. In contrast, patients labelled as “hyperhydrated” had a negative cumulative
fluid balance after 5 days of observation in ICU. The authors concluded that BIVA
measurement of hydration status is likely valid and may be useful in critically ill
patients [27].
Samoni and Colleagues, in a similar study carried out in ICU, found that severe
hyperhydration measured with BIVA was the only variable significantly associated
with long term ICU mortality (OR 22.91; p < 0.001) [28].
However, many BIVA limitations have been acknowledged in critically ill
patients.
Acute c
limiting its ability to monitor rapid measurement of body water content [29].
Moreo
given by muscle mass. Considering that muscle mass is rapidly lost during the first
days of critically illness, incorrect estimation of BIVA parameters could increase
biased volume estimation.
hanges i
ver, estimation
n volume status, for example, could not be detected by BIVA,
of hydration status relies on fat-free mass, which is
mainly

11 Bioelectrical Impedance Vector Analysis in Critically Ill Patients 123
Further evidence demonstrated that natriuretic peptides blood levels may not
correlate with BIVA parameters in patients with heart failure [30]. This means that
hydration status alone is not the main actor that guides fluid therapy in ICU [31].
As a result, BIVA could be considered a supportive bedside tool to evaluate
hydration status in critically ill patients that, together wi th clinical evaluation and
other tools (for example ultrasound of the inferior vena cava or lung ultrasound
(LUS) score), may provide clinicians with supportive information on hydration
status and help guide fluid management in critically ill patients [32, 33].
Body Composition and Nutrition in ICU
Patients with long stays in ICU experience deep changes in their body composition.
Muscle wasting and ICU acquired weakness are probably the most clinically
evident events [
modified by critical illness as shown in Fig. 11.2.
It is important to define muscle mass in ICU. Rapid loss of muscle mass predicts
higher ICU mortality [36]. Interestingly, rapid muscle mass depletion affects also
physical functioning and quality of life even months or years after ICU discharge
[37, 38].
Some evidence demonstrated that there is good correlation between muscle mass
determined with BIVA compared to CT-muscle mass investigated at the third
lumbar vertebra [39]. Similarly, low PhA values correlates well with low skeletal
muscle mass and muscular density. In this way, BIVA seems useful to help
34, 35]. However, TBW, fat mass, and bone mineral density are also
HEALTHY INDIVIDUAL
Protein
ICW
ECW
TBW
Mineral mass
Fat mass
BCM
FFM
Body
Weight
ICU PATIENT
BCM
FFM
Body
Weight
Protein
TBW
Mineral mass
Fat mass
ICW
ECW
Fig. 11.2 Body composition changes in critically ill patients. Each body component is altered
during and after ICU stay, although TBW and protein compartment are probably the most affected.
Notwithstanding, also fat and mineral mass do not remain unaltered after critically illness. Legend:
ICW intracellular water, ECW extracellular water, TBW total body water (ICW + ECW), BCM body
cell mass, FFM fatty-free mass

124 C. Deana et al.
clinicians identify sarcopenic patients who are at very high risk of adverse outcomes
in ICU.
Moreover, in a small sample of critically ill patients, Lambell and colleagues
a significant correlation between PA and CT-muscle mass density [
found
9].
Evidence supports the validity of BIVA in estimating muscle mass when com-
pared to DEXA; however, the patients assessed were also from non-ICU setting
[40, 41].
Decrease in body cell mass (BCM) is v ery common in ICU and represents a
potential injury that contributes to ICU-AW.
Despite some unavoidable muscle mass reduction, the identification of patients
with great muscle loss during ICU stay might allow for a closer follow-up after
discharge.
Adequate caloric and protein intake is important during critical illness. If on the
one hand early full nutritional support seems harmful, on the other hand, poor intake
after clinical stabilization confers higher mortality in critically ill patients [42]. Consequently, timing and dosing of energy/protein delivery remains an open question,
also considering some side effects of artificial nutrition [43].
Indirect calorimetry (IC) measures energy expenditure (EE) through the analysis
of inhaled/exhaled gases. IC is a reliable method to measure EE and it has been
validated and compared to direct calorimetry. Recent guidelines suggest targeting
caloric needs with the use of IC [44].
However, IC is not widely used, many formulas are available to estimate the EE
and the caloric needs of ICU patients. Finally, fixed doses based on patient’s weight
are frequently used to simplify nutritional prescription.
Physiologically, the metabolic active part of free fat-mass is represented by body
cell mass (FFM).
Considering this concept, some BIA machines provide basal metabolic rate
estimation using equations that consider FFM. However, these equations are less
accurate than indirect calorimetry [45].
In addition, data from ICU patients on this issue are still lacking.
Another interesting potential use of BIVA is to calculate the protein dosage based
on FFM (sometimes called also lean body mass) derived from bioimpedance.
Protein dosing should consider FFM. However, this prescription becomes diffi-
cult whenever patients are not at their ideal body weight (or FFM). Many ICU
patients are overweight and, frequently even obese. Considering that obese patients
are more prone to become sarcopenic, it is difficult to determine the exact amount of
protein for nutritional planning [46].
In this regard, a recent study on COVID-19 population compared FFM derived
from BIA to four formulas. It demonstrated that none of these had acceptable
agreement after Bland-Altman analysis [47].
Consequent
IA may be a useful bedside tool to optimize protein target in ICU
ly, B
patients.
Moreover,
BIA may be helpful in the post-ICU recovery phase when adequate
calories and protein intake are extremely important for the restoration of
muscle mass.

11 Bioelectrical Impedance Vector Analysis in Critically Ill Patients 125
Limits of BIVA in Critically Ill Patients
Although there are many advantages for BIA in ICU, some limitations in addition to
those already listed above need to be acknowledged.
BIVA derived parameters are determined considering a healthy population, in
whom fixed proportion s between compartments can be assumed. However, critically
ill patients who are subjected to great rapid fluid shifts these assumptions may be
violated. In fact, important hemodynamic derangements in ICU require rapid interventions to restore optimal organ perfusion. Besides vasopressors and inotropes,
fluid challenges are frequently performed in critically unstable patients. During the
early resuscitation phase of septic shock, but also if the patient is suffering from
hemorrhagic shock, large amounts of fluids alter the physiological distribution
across body compartments. BIVA is unable to detect this rapid change, so some
errors could easily be present in the definition of derived parameters.
In this regard, PA is one of the main parameters that is affected by large fluid shift.
Similarly, in case of muscular edema, muscle mass could be overestimated because it
is calculated at a constant FFM hydration.
Another important aspect to consider is the presence of ascites and pleural
effusions, given that they represent an accumulation of extravascular fluids that,
when whole body BIVA is adopted, can influence measurements.
Hyper- or hyponatremia could alter the ECW estimation because of lower or
higher extracellular resistance respectively.
Another problem with BIVA is that many ICU patients are connected to machines
(ventilators or dialysis machines or chest drains) which lead to electrical flux
dispersion to environment in a way that cannot be reliably quanti fied.
Finally, one of the main caveats is the absence of standard ICU reference and
cut-off values.
Conclusions
In conclusion, while BIVA shows promise as a bedside tool for assessing hydration
status and body composition in critically ill patients, its limitations should be
carefully considered. It is recommended as a supportive tool alongside clinical
evaluation and other diagnostic techniques. The review encourages further research
to establish standard reference values for BIVA in the ICU setting.
References
1. O’Connor ME, Prowle JR. Fluid overload. Crit Care Clin. 2015;31:803–21.
Silversides JA,
2.
ill patients. Intensive Care Med. 2019;45(10):1440–2. https://doi.org/10.1007/s00134-019-
05713-y. Epub 2019 Aug 9. PMID: 31399779.
Perner A, Malbrain MLNG. Liberal versus restrictive fluid therapy in critically
Соседние файлы в папке Библиотека им академика М.И. Перельмана
